Evidence map›Paper›PMID 31350420›Full record

ArticleScientific reports2019

Genetic variation across RNA metabolism and cell death gene networks is implicated in the semantic variant of primary progressive aphasia.

Luke W Bonham, Natasha Z R Steele, Celeste M Karch, Iris Broce, Ethan G Geier, Natalie L Wen, Parastoo Momeni, John Hardy, Zachary A Miller, Maria Luisa Gorno-Tempini and 10 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Temporopolar regions of the human brain.Brain : a journal of neurology · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 20 institutions in 13 countries.

Luke W BonhamMemory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, CA, USA.
Natasha Z R SteeleMemory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, CA, USA.
Celeste M KarchDepartment of Psychiatry, Washington University, St. Louis, MO, USA.
Iris BroceNeuroradiology Section, Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0003-4932-1430
Ethan G GeierMemory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, CA, USA.
Natalie L WenDepartment of Psychiatry, Washington University, St. Louis, MO, USA.
Parastoo MomeniTexas Tech University Health Science Center, Laboratory of Neurogenetics, Lubbock, TX, USA.
John HardyDepartment of Molecular Neuroscience, UCL Institute of Neurology, London, UK.
Zachary A MillerMemory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-5991-3053
Maria Luisa Gorno-TempiniMemory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, CA, USA.
Christopher P HessNeuroradiology Section, Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA, USA.
Patrick LewisDepartment of Molecular Neuroscience, UCL Institute of Neurology, London, UK.ORCID http://orcid.org/0000-0003-4537-0489
Bruce L MillerMemory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, CA, USA.
William W SeeleyMemory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, CA, USA.
Claudia ManzoniDepartment of Molecular Neuroscience, UCL Institute of Neurology, London, UK.
Rahul S DesikanNeuroradiology Section, Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA, USA.
Sergio E BaranziniDepartment of Neurology, University of California, San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0003-0067-194X
Raffaele FerrariDepartment of Molecular Neuroscience, UCL Institute of Neurology, London, UK.
Jennifer S YokoyamaMemory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, CA, USA. Jennifer.Yokoyama@ucsf.edu.
International FTD-Genomics Consortium (IFGC)
University of California, San Francisco · USUNSW Sydney · AUAmsterdam UMC Location Vrije Universiteit Amsterdam · NLInserm · FRMayo Clinic · USNewcastle Hospitals - Campus for Ageing and Vitality · GBSalford Royal Hospital · GBUniversity College London · GBJacksonville College · USSaarland University · DEUK Dementia Research Institute · GBUniversity of Antwerp · BEUniversity of Florence · ITUniversity of Milan · ITWashington University in St. Louis · USCentro San Giovanni di Dio Fatebenefratelli · ITFondazione IRCCS Istituto Neurologico Carlo Besta · ITFundació ACE · ESLund University · SEMRC Prion Unit · GB

Funding

TDP-43 Loss-of-Function: Biology to BiomarkersP01AG019724 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Jennifer Merrilees · 2002 to 2026
$67.2M
ABCD-USA Consortium: Data Analysis, Informatics and Resource CenterU24DA041123 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ANDERS M DALE · 2015 to 2026
$51.5M
Research Education ComponentP30AG062422 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Gil Dan Rabinovici · 2019 to 2026
$36.9M
PrPSc SPECIFIC INTERACTION WITH NOVEL PrP-Fc FUSION PROTEINSP50AG023501 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HUANG, YADONG · 2004 to 2018
$27.1M
ABCD-USA Consortium: Research ProjectU01DA041106 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mary M Heitzeg, Chandra Sekhar Sripada · 2015 to 2026
$24.9M
ABCD-USA Consortium: Research ProjectU01DA041148 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI Damien A Fair, Rebekah S Huber · 2015 to 2026
$22.3M
ABCD-USA: NYC Research ProjectU01DA041174 · NIDA · YALE UNIVERSITY · PI Arielle Ryan Baskin-Sommers, Betty J Casey · 2015 to 2026
$19.7M
15/21 ABCD-USA Consortium: Research Project Site at LIBRU01DA050989 · NIDA · LAUREATE INSTITUTE FOR BRAIN RESEARCH · PI ROBIN L AUPPERLE, MARTIN P. PAULUS · 2020 to 2026
$14.7M
ABCD-USA Consortium: Research ProjectU01DA041022 · NIDA · SRI INTERNATIONAL · PI Fiona C Baker, Eva M Muller-Oehring · 2015 to 2026
$13.4M
Scientific training in addiction research techniques (START) for gifted future investigators from historically underrepresented and underserved backgroundsU01DA051039 · NIDA · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI HUGH P. GARAVAN, ALEXANDRA S POTTER · 2020 to 2026
$12.0M
ABCD-USA Consortium: UWM SIte U01DA041025 · NIDA · UNIVERSITY OF WISCONSIN MILWAUKEE · PI Christine L Larson, Krista Maurine Lisdahl · 2017 to 2026
$11.2M
Progressive Aphasia Cognition Anatomy and ProgressionR01NS050915 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MARIA LUISA GORNO TEMPINI · 2004 to 2026
$11.0M
Medical Research Council G0301152Medical Research Council MC_U123160651Medical Research Council MC_UU_00024/1Medical Research Council MR/L010933/1Medical Research Council MR/N026004/1NIA NIH HHS K01 AG046374NIA NIH HHS K01 AG049152NIA NIH HHS P01 AG019724NIA NIH HHS P30 AG062422NIA NIH HHS P50 AG023501NIA NIH HHS U01 AG052943NIDA NIH HHS U01 DA041022NIDA NIH HHS U01 DA041025NIDA NIH HHS U01 DA041093NIDA NIH HHS U01 DA041106NIDA NIH HHS U01 DA041148NIDA NIH HHS U01 DA041174NIDA NIH HHS U01 DA050989NIDA NIH HHS U01 DA051039NIDA NIH HHS U24 DA041123NIDCD NIH HHS K24 DC015544NINDS NIH HHS R01 NS050915NINDS NIH HHS R01 NS100440NINDS NIH HHS R56 NS050915
6 · The paper itself

Abstract

The semantic variant of primary progressive aphasia (svPPA) is a clinical syndrome characterized by neurodegeneration and progressive loss of semantic knowledge. Unlike many other forms of frontotemporal lobar degeneration (FTLD), svPPA has a highly consistent underlying pathology composed of TDP-43 (a regulator of RNA and DNA transcription metabolism). Previous genetic studies of svPPA are limited by small sample sizes and a paucity of common risk variants. Despite this, svPPA's relatively homogenous clinicopathologic phenotype makes it an ideal investigative model to examine genetic processes that may drive neurodegenerative disease. In this study, we used GWAS metadata, tissue samples from pathologically confirmed frontotemporal lobar degeneration, and in silico techniques to identify and characterize protein interaction networks associated with svPPA risk. We identified 64 svPPA risk genes that interact at the protein level. The protein pathways represented in this svPPA gene network are critical regulators of RNA metabolism and cell death, such as SMAD proteins and NOTCH1. Many of the genes in this network are involved in TDP-43 metabolism. Contrary to the conventional notion that svPPA is a clinical syndrome with few genetic risk factors, our analyses show that svPPA risk is complex and polygenic in nature. Risk for svPPA is likely driven by multiple common variants in genes interacting with TDP-43, along with cell death,x` working in combination to promote neurodegeneration.

Indexed as

Gene Regulatory NetworksPolymorphism, Single NucleotideApoptosisCohort StudiesDatabases, GeneticDNA-Binding ProteinsGene Expression RegulationGenome-Wide Association StudyHumansPrimary Progressive Nonfluent AphasiaProtein Interaction MapsRisk FactorsRNATranscription, GeneticDNA-Binding ProteinsRNATARDBP protein, human

Identifiers

PMID31350420
PMCPMC6659677
OpenAlexW2966019081

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.